Nakashima K, Aoshima M, Ohfuji S, Suzuki K, Katsurada M, Katsurada N, Misawa M, Otsuka Y, Kondo K, Hirota Y (2017) Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
Small series confirm simultaneous LT + SGs safety, minimal adverse effects, and benefits in weight loss, comorbidity resolution, and MASLD prevention [25, 59]
It is important to note that weight loss with tirzepatide is gradual and progressive rather than immediate
Treatment of polycystic ovary syndrome in adults
This typically begins within the first two weeks, peaks during weeks six through eight, and resolves substantially by week twelve for most users
Suspected adverse reactions to any unlicensed product should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk